<?xml version="1.0" encoding="utf-8"?><!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN"  "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd"><ArticleSet><Article><Journal><PublisherName>eLife Sciences Publications, Ltd</PublisherName><JournalTitle>eLife</JournalTitle><Issn>2050-084X</Issn><Volume>5</Volume><PubDate PubStatus="epublish"><Year>2016</Year><Month>April</Month><Day>25</Day></PubDate></Journal><ArticleTitle>The eLife research article</ArticleTitle><ELocationID EIdType="doi">10.7554/eLife.00666</ELocationID><ELocationID EIdType="pii">e00666</ELocationID><Language>EN</Language><AuthorList><Author EqualContrib="Y"><FirstName>Melissa</FirstName><LastName>Harrison</LastName><Suffix>Jnr</Suffix><Affiliation>Department of Production, eLife, Cambridge, United Kingdom</Affiliation><Identifier Source="ORCID">https://orcid.org/0000-0003-3523-4408</Identifier></Author><Author EqualContrib="Y"><FirstName>James F</FirstName><LastName>Gilbert</LastName><Affiliation>Department of Production, eLife, Cambridge, United Kingdom</Affiliation></Author><Author EqualContrib="Y"><CollectiveName>eLife Editorial Production Group</CollectiveName><Affiliation>Department of Production, eLife, Cambridge, United Kingdom</Affiliation></Author><Author EqualContrib="Y"><CollectiveName>eLife Technology Group</CollectiveName><Affiliation>Department of Technology, eLife, Cambridge, United Kingdom</Affiliation></Author></AuthorList><GroupList><Group><GroupName>eLife Editorial Production Group</GroupName><IndividualName><FirstName>Alistair</FirstName><LastName>Shearer</LastName></IndividualName><IndividualName><FirstName>Hannah</FirstName><LastName>Caton</LastName></IndividualName><IndividualName><FirstName>Wei Mun</FirstName><LastName>Chan</LastName></IndividualName><IndividualName><FirstName>Hannah</FirstName><LastName>Drury</LastName></IndividualName><IndividualName><FirstName>Maria</FirstName><LastName>Guerreiro</LastName></IndividualName><IndividualName><FirstName>Susanna</FirstName><LastName>Richmond</LastName></IndividualName></Group><Group><GroupName>eLife Technology Group</GroupName><IndividualName><FirstName>Graham</FirstName><LastName>Nott</LastName></IndividualName><IndividualName><FirstName>Chris</FirstName><LastName>Wilkinson</LastName></IndividualName><IndividualName><FirstName>Luke</FirstName><LastName>Skibinski</LastName></IndividualName></Group><Group><GroupName>for the eLife Staff Team</GroupName><IndividualName><FirstName EmptyYN="Y"/><LastName>for the eLife Staff Team</LastName></IndividualName></Group></GroupList><PublicationType>Journal Article</PublicationType><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.00666</ArticleId><ArticleId IdType="pii">00666</ArticleId></ArticleIdList><History><PubDate PubStatus="received"><Year>2016</Year><Month>03</Month><Day>01</Day></PubDate><PubDate PubStatus="accepted"><Year>2016</Year><Month>04</Month><Day>01</Day></PubDate></History><Abstract><AbstractText Label="">This is the abstract. This article will describe the eLife article and the process.
                    An abstract can contain any formatting, such as <i>italics</i>,
                        <b>bold</b>, <sup>superscript</sup>, <sub>subscript</sub> or small caps. MathML is
                    also allowed: 
                    [Formula: see text]
                .</AbstractText><AbstractText Label="">eLife does not structure abstracts into sub headings expect in a clinical trial article, but the abstract can have
                    multiple paragarahs. The sub DOI is always .001 as it is the first asset in any
                    article. I have added an unmatched &gt; bracket as this has been an issue for PubMed deposits in the past.</AbstractText><AbstractText Label="">If this was a clinical trial the clinical trial details would be listed at the end of the abstract:</AbstractText><AbstractText Label="">Clinical trial Registration: EudraCT2004-000446-20.</AbstractText><AbstractText Label="Editorial note">This article has been through an editorial process 
                 in which the authors decide how to respond to peer review. The Editor's assessment 
                is that the author responses are thorough and rigorous (see decision letter).</AbstractText></Abstract><CopyrightInformation>Â© 2016, Harrison et al</CopyrightInformation><CoiStatement>MH Chair of JATS4R, JG No competing interests declared,  Graham Nott is not an eLife employee</CoiStatement><ObjectList><Object Type="keyword"><Param Name="value">human</Param></Object><Object Type="keyword"><Param Name="value">machine</Param></Object><Object Type="keyword"><Param Name="value">cell biology</Param></Object><Object Type="keyword"><Param Name="value">plant biology</Param></Object><Object Type="keyword"><Param Name="value">XML</Param></Object><Object Type="keyword"><Param Name="value">Housestyle</Param></Object><Object Type="keyword"><Param Name="value">eLife</Param></Object><Object Type="keyword"><Param Name="value">
formatting
</Param></Object><Object Type="grant"><Param Name="id">F32 GM089018</Param><Param Name="grantor">Howard Hughes Medical Institute</Param></Object></ObjectList></Article></ArticleSet>